---
schema_version: "secwatch.filing_event.v1"
accession: "0001493152-22-029450"
form_type: "8-K"
ticker: "CTOR"
cik: "0001851484"
company_name: "CITIUS ONCOLOGY, INC."
filed_at: "2022-10-24T23:59:59+00:00"
generated_at: "2026-06-23T01:43:58.488705+00:00"
event_type: "other_material"
sentiment: "neutral"
materiality_score: 0.65
calibrated_materiality_score: 0.65
confidence: "high"
source: SEC EDGAR
---

# TenX Keane Acquisition closes IPO, raises $66M in gross proceeds

## Summary
- IPO of 6,600,000 units at $10.00/unit closed on Oct 18, 2022; gross proceeds $66,000,000.
- Simultaneous private placement of 394,000 units to sponsor at $10.00/unit generated $3,940,000 additional.
- Total of $67,320,000 placed in trust account ($10.20 per unit) for benefit of public shareholders.
- Audited balance sheet shows $453,111 shareholders' deficit; going concern note highlights risk if business combination not completed within 9-month period.

## SEC filing metadata
- accession: 0001493152-22-029450
- form_type: 8-K
- ticker: CTOR
- cik: 0001851484
- company_name: CITIUS ONCOLOGY, INC.
- filed_at: 2022-10-24T23:59:59+00:00
- event_type: other_material
- sentiment: neutral
- materiality_score: 0.65
- calibrated_materiality_score: 0.65
- confidence: high
- sec_items: 8.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1851484/000149315222029450/0001493152-22-029450-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1851484/000149315222029450/form8-k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001493152-22-029450
- JSON: https://secwatch.observer/filing/0001493152-22-029450.json
- Plain text: https://secwatch.observer/filing/0001493152-22-029450.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.